Is It Still Safe To Buy ARM Holdings plc?

In this uncertain market, should you still buy ARM Holdings plc (LON: ARM)?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m always searching for shares that can help ordinary investors like you make money from the stock market. However, many people are currently worried the market has been overheating.

So right now I’m analysing some of the most popular companies in the FTSE 100, hoping to establish if they can continue to outperform in today’s uncertain economy.

Today I’m looking at microchip designer ARM (LSE: ARM) (NASDAQ: ARMH.US) to determine whether the shares are still safe to buy at 830p.

So, how’s business going?

Over the last year or so, investors have been excited by ARM’s performance as the company’s profits surged higher, led by an ever-increasing demand for smaller, faster smartphones and devices.

Indeed, it would appear that this tech trend is not going to stop any time soon, as for the first quarter of this year, ARM reported a 31% year-on-year rise in pre-tax profit.

Having said that, some City analysts have started expressing concerns about the company’s ability to maintain the rapid rate of earnings growth, as sales at the firm’s largest customer, Apple are starting to slow.

In addition, analysts have raised concerns that the firm’s larger peer, Intel, is starting to muscle in on ARM’s dominance in the mobile processor market by offering technology of a similar nature.

Expected growth

Despite concerns about increasing competition in the sector and slowing sales at Apple, City analysts remain upbeat about ARM’s outlook.

City forecasts currently predict earnings of 21p per share for this year (40% growth) and 25p for 2014.

Shareholder returns

Unfortunately, ARM does not provide its shareholders with much in the way of cash returns and currently the company offers a dividend yield of only 0.6%.

Still, ARM’s management is committed to a progressive dividend policy and is expected to increase the payout 24% this year, to 5.6p a share, giving the company a prospective yield of 0.7%.

Valuation

As a fast-growing technology company, ARM has seen investors prepared to pay a premium for its shares. ARM trades at a historic P/E of 55, while its peers trade at an average historic P/E of around 42.

That said, ARM is on-track to grow earnings around 40% this year, which gives a PEG ratio of 1.3, indicating that the share price is only slightly expensive for the near-term earnings growth the firm is expected to produce.

Foolish summary

ARM’s rate of growth has been impressive during the past few year and many believe this trend will continue.

However, the firm currently trades at a very high P/E ratio and in this uncertain market, shares that are trading at a high valuation such as ARM are usually the most volatile.

So, all in all, due to the firm’s high valuation, I feel that ARM does not look safe to buy at 830p.

More FTSE opportunities

Although I feel that it is not safe to buy ARM, I am more positive on the five FTSE shares highlighted within this exclusive wealth report.

Indeed, all five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On“.

Just click here for the report — it’s free.

In the meantime, please stay tuned for my next FTSE 100 verdict

> Rupert does not own any share mentioned in this article.

More on Investing Articles

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

What’s a realistic goal to aim for when building a SIPP?

How big (or small) should someone dream when building up a SIPP? That depends on a number of different factors,…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

A once-in-a-decade chance to buy these 3 beaten-down FTSE 100 shares

Harvey Jones picks out three FTSE 100 stocks that have had a difficult decade, but says they're a lot cheaper…

Read more »

National Grid engineers at a substation
Investing Articles

Here’s what 100 National Grid shares bought 5 years ago are worth now

Christopher Ruane looks at how National Grid shares have performed over the past few years and weighs whether he ought…

Read more »

Red lorry on M1 motorway in motion near London
Investing Articles

Up 242% in 2 years! Can anything stop the rampant Barclays share price?

Harvey Jones says the Barclays share price has been racing along lately but questions how long the FTSE 100 bank…

Read more »

Investing Articles

Can these FTSE 250 dividend stocks with big yields shine in 2026?

Here are two dividend stocks with forecast yields of 8.6% and 6.8% after years of steady payouts, and with earnings…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

Up 17% today! Is Wise still worth considering for a Stocks and Shares ISA?

Wise put a smile on the face of anyone holding it in a Stocks and Shares ISA today. What news…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

See how the Rolls-Royce share price has transformed £10,000 in just 3 years – it’s jaw-dropping

Harvey Jones is blown away by the Rolls-Royce share price and examines whether the FTSE 100 growth star can make…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

How can we aim for a penny share fortune in 2026?

Should penny share investors be getting excited about the prospects for 2026? With care, we can unearth some attractive candidates.

Read more »